Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa1g03400 | ATGAATATGTCTTTGGTTCTATTATTTCATCTTTTGCTTCTTGTCTTTTGTTGTATCTCTTCATTTGCTAGTGGAGCTACTCTCTTAGAAGAAGAAGTACAAGTTATGAAAGACATAGCTAAGACACTTAGGAAGAATGATTGGGATTTCAGCATAGATCCATGTAGTGGACAAAGTAATTGGACATCTTCAGTGCAAGTGAAAGGGTTTGAAAATGCTGTCACTTGCAATTGCACTTTTGCCAATGCCACTATCTGCCATATTGTAAGCATTGTTCTAAAGTCACAAAATCTTTCTGGCACACTTCCAAGGGAACTTGTGAAATTACCTTACCTCCAACAAATTGATCTCACACGTAACTACCTTAACGGTACAATCCCTCCACAATGGAGCTCCATCAATCTTGTCAACATTTCACTATTTGGAAATCGCTTAACAGGTCCAATTCCAAAAGAATTTGGAAAAATCACCACCTTGAAAAGCTTGGTTTTGGAATTCAATCACTTTTCCGGAAAGCTTCCTCCGGAGCTTGGGAATCTTCACCAGCTTGAAAGATTGCTTCTTACTTCCAACTATTTTACTGGAAATTTACCAGCTACATTTGCTAAGCTCACTAAACTTAAGTACCTTCGACTTGGCGACAATCAGTTCTCTGGGACTATTCCTGTTTTCATTCAGAGTTGGACAAGTCTTGAGAGGCTGGTCATACAAGGGAGTGGTTTAAGTGGTCCAGTTCCTTCTGCAATTTCATATCTGAAAAATCTCACCGACTTGAGAATAAGTGACTTGAAAGGATCAGATTCTCCTTTTCCGCAACTTATTAACTTGACAAATTTGGAAACATTAGTATTGAGGAGTTGCAATCTTATAGGAACAGTTCCTGAGTATCTTGGAAATATCACCAATTTAAGATCATTAGACCTAAGTTTTAACAAGTTAAGTGGAAAAATTCCGAACACCTTGGGTGGCTTGGAGAACATAAATATACTATACTTAACTGGAAACCTTTTTACTGGACCACTGCCAAATTGGATAGCTAGACCGGACTACACAGATCTTTCGTATAACAATTTGACCATTGAAAATCCAGAGCAGTTGACATGTCAACAGGGAACCTTGAACTTGTTTGCATCATCTTCAGAGGGAAGTAACTTGGGAACGGTTTCATGTTTGGGGAACATTGGTTGTCCTAAAACTTGGTACTCTCTCCATATAAATTGCGGTGGTAAGCTCATAACCTCAAATGAGAGCTTGACATATGACGATGATTCATATGAAGTTGGACCAGCAAGCTTTCACCGGACTGAATCAAACTGGGCACTCAGCAACACTGGTCACTTTTTTGATAGTGGCCTTGTGGACTACTATACCTGGTCTAATACAACTGACCTTAACATCGACAACGGAGAACTGTATATGGATGCACGCGTTTCTCCTCTTTCTCTAACATATTATGGGTTTTGCCTGGGAAATGGAAACTACTCAGTAAAACTCCATTTTGCAGAGATAATGTTCACCGATGATCAAACATATAATAGCCTTGGAAGGCGCATATTTGACATATATGTTCAGAGAAGGCTGGTGCTGAAGGATTTCGATATTGCAAAAGAAGCTGGTGGAGTTGGTAAGGCAATCATAAAGAATTTCACTGCTGTTGTGACTAGTAATACCTTGGAGATTCGCCTTCAGTGGGCTGGGAAAGGGACAACTGCTATTCCATTTGGATCCGTATATGGTCCTCTTATATCGGCTATATCGGTTGATCCTGACTTTACACCCCCGGTGGAAAAAGGAAGTGGCATACATGGGTGGGATATTGTTGCAGTTGTAGTTGCTGGAGCACTATTTATCTTCATCTTATTTGGTATAGCTCAGTGGAGAAGACGTCGACGACGACAAATAGGTCCTCTAGAAAGAGAGGTAAAGGGTTTAGATTTCCAACCTGGGTTGTTTACTTTACGGCAAATCAAAGCAGCAACTAACAACTTCGATATAGCCTTCAAAATTGGAGAAGGAGGGTTTGGTCCTGTTTACAAGGGTGTTCTTACGGACGGCACAACAGTAGCAGTTAAGAAACTTTCTTCAAAATCAAAGCAAGGGAATCGCGAATTTATAAATGAGATTGGCTTGATTTCTGCTTTGCAACACCCATGTCTAGTTAAGCTCTATGGTTGTAGTATGGAGGGAGATCAGTTATTGCTGATATATGAGTACATGGAAAATAATAGCCTTGCTTGTGCTTTGTTTGCCAGAGGAAAAGATCAATTGAAACTGGCTTGGTCGACAAGGAAGAGAATTTGCGTTGGTATCGCTAGAGGTTTGGCTTATCTTCATGAAGAATCGAGACTAAAAATAGTTCACAGAGACATCAAGGCTACTAATGTGTTACTGGATAAAGATCTCAATCCAAAGATATCTGATTTTGGTTTGGCTAAGCTTAAAGATGACGGATACACTCATATAACCACTAGAGTAGCTGGCACTTATGGATATATGGCTCCAGAATATGCTATGCACGGATATTTGAGTGAGAAAGCAGATGTTTATAGTTTTGGAGTTGTTGCCTTGGAAATTGTTAGTGGGAAGCACAATACCATGAGTTGGCCTAAGGAAGAATGCTTCTCTATTGTTGATTGGGTGCATCTCTTGAAAGAAGAAGGTAATATAATGGACCTAGTTGATGAAAGATTAGGTGAAGATTTCGAAAAAGAGGAAGTAATGGTCATGATCAATGTGGCTCTTTTATGCACTCATGTTTCTCCAATGCACAGGCCAACCATGTCATCAGTGGTAAGCATGCTTGAAGGAAAATCTGTTGTTGAAGAAGTTGTGTCCGACACAAGCCAAGTTTTTGAAGGGAAAAAGTTGGAGATGATTCAACAGTATTACCAACAAGGTGAAAAAAATGTTGCGCCTGAGACTGAGACTGAGGAAGAGAGCATCTTAATAGATGCAACTGCAGAATACATGTCTGATACAAATCTACATTCTGTTAACATGGATTCTCCTTATAGAAGTTTCAACACTCTGTAA | 3033 | 0.3966 | MNMSLVLLFHLLLLVFCCISSFASGATLLEEEVQVMKDIAKTLRKNDWDFSIDPCSGQSNWTSSVQVKGFENAVTCNCTFANATICHIVSIVLKSQNLSGTLPRELVKLPYLQQIDLTRNYLNGTIPPQWSSINLVNISLFGNRLTGPIPKEFGKITTLKSLVLEFNHFSGKLPPELGNLHQLERLLLTSNYFTGNLPATFAKLTKLKYLRLGDNQFSGTIPVFIQSWTSLERLVIQGSGLSGPVPSAISYLKNLTDLRISDLKGSDSPFPQLINLTNLETLVLRSCNLIGTVPEYLGNITNLRSLDLSFNKLSGKIPNTLGGLENINILYLTGNLFTGPLPNWIARPDYTDLSYNNLTIENPEQLTCQQGTLNLFASSSEGSNLGTVSCLGNIGCPKTWYSLHINCGGKLITSNESLTYDDDSYEVGPASFHRTESNWALSNTGHFFDSGLVDYYTWSNTTDLNIDNGELYMDARVSPLSLTYYGFCLGNGNYSVKLHFAEIMFTDDQTYNSLGRRIFDIYVQRRLVLKDFDIAKEAGGVGKAIIKNFTAVVTSNTLEIRLQWAGKGTTAIPFGSVYGPLISAISVDPDFTPPVEKGSGIHGWDIVAVVVAGALFIFILFGIAQWRRRRRRQIGPLEREVKGLDFQPGLFTLRQIKAATNNFDIAFKIGEGGFGPVYKGVLTDGTTVAVKKLSSKSKQGNREFINEIGLISALQHPCLVKLYGCSMEGDQLLLIYEYMENNSLACALFARGKDQLKLAWSTRKRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLKDDGYTHITTRVAGTYGYMAPEYAMHGYLSEKADVYSFGVVALEIVSGKHNTMSWPKEECFSIVDWVHLLKEEGNIMDLVDERLGEDFEKEEVMVMINVALLCTHVSPMHRPTMSSVVSMLEGKSVVEEVVSDTSQVFEGKKLEMIQQYYQQGEKNVAPETETEEESILIDATAEYMSDTNLHSVNMDSPYRSFNTL | 1010 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa1g03400 | 1010 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 739 | 946 | - | - | |
Vifa1g03400 | 1010 | ProSiteProfiles | Protein kinase domain profile. | 663 | 940 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa1g03400 | 1010 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 400 | 590 | - | - | |
Vifa1g03400 | 1010 | Pfam | Protein tyrosine and serine/threonine kinase | 668 | 934 | IPR001245 | GO:0004672|GO:0006468 | |
Vifa1g03400 | 1010 | Coils | Coil | 26 | 46 | - | - | |
Vifa1g03400 | 1010 | SUPERFAMILY | Protein kinase-like (PK-like) | 645 | 939 | IPR011009 | - | |
Vifa1g03400 | 1010 | CDD | STKc_IRAK | 669 | 936 | - | - | |
Vifa1g03400 | 1010 | Pfam | Leucine rich repeat | 277 | 336 | IPR001611 | GO:0005515 | |
Vifa1g03400 | 1010 | Gene3D | - | 400 | 589 | - | - | |
Vifa1g03400 | 1010 | Gene3D | Ribonuclease Inhibitor | 265 | 376 | IPR032675 | - | |
Vifa1g03400 | 1010 | Gene3D | Ribonuclease Inhibitor | 192 | 264 | IPR032675 | - | |
Vifa1g03400 | 1010 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 270 | 368 | - | - | |
Vifa1g03400 | 1010 | Gene3D | Transferase(Phosphotransferase) domain 1 | 739 | 951 | - | - | |
Vifa1g03400 | 1010 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase isoform A | 32 | 191 | - | - | |
Vifa1g03400 | 1010 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 13 | 959 | - | - | |
Vifa1g03400 | 1010 | SUPERFAMILY | L domain-like | 82 | 359 | - | - | |
Vifa1g03400 | 1010 | Gene3D | Ribonuclease Inhibitor | 29 | 191 | IPR032675 | - | |
Vifa1g03400 | 1010 | Pfam | Malectin domain | 402 | 585 | IPR021720 | - | |
Vifa1g03400 | 1010 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 632 | 738 | - | - | |
Vifa1g03400 | 1010 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 785 | 797 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa1g03400 | 1010 | ProSiteProfiles | Leucine-rich repeat profile. | 302 | 325 | IPR001611 | GO:0005515 | |
Vifa1g03400 | 1010 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase isoform A | 197 | 264 | - | - | |
Vifa1g03400 | 1010 | SMART | serkin_6 | 663 | 934 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa1g03400 | 1010 | Gene3D | Phosphorylase Kinase; domain 1 | 629 | 738 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa1g03400 | Vifa-Chr1 | 529872450 | 529893219 | Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa1g03400 | 19 | 986 | Receptor kinase-like Gene Family | AT1G53420 | 52.658 | 0.0 | 996 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_DLSV | Vifa1g03400 | PK_Tyr_Ser-Thr | 1.4e-47 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa1g03400 | - | - | psat:127081874 | 1733.38 |